A 2022 journal club examining the LOVIT trial of intravenous vitamin C in ICU patients with sepsis receiving vasopressors. It reviews death and persistent organ dysfunction outcomes, and reflects on how early enthusiasm for a treatment should be tested by stronger evidence.